Hyperpigmentation of the teeth and tongue may occur in skin cancer patients receiving etoposide, prednisolone, vincristine, and cyclophosphamide treatment
Abstract
Cutaneous extranodal non-Hodgkin lymphoma is an unusual cancer that often responds to chemotherapeutic drugs including cyclophosphamide, vincristine, and etoposide. Hyperpigmentation of the nails and skin is an extremely rare side effect of these medications. A case of hyperpigmentation that extended to the tongue and teeth is shown here, however. Teeth and the tongue started to hyper pigment soon after chemotherapy began. Within a week, the hyperpigmentation cleared up without the need for any medication, surgery, or changes to one's way of life
References
Cutaneous T-cell lymphoma is the subject of Pulitzer M. Clinical laboratory medicine 2017;37:527–46.
The 2016 update on the diagnosis, risk-stratification, and treatment of cutaneous T-cell lymphoma was published by Wilcox RA. Published in 2016 in the American Journal of Hematology, volume 91, pages 151–165.
Kotz EA, Thiers BH, Anderson D. Skin T-cell lymphoma. Johns Hopkins University Journal of Dermatology and Venereology, 2003, 17(1), 131–137.
Latkowski JA, Lo Sicco K, Weed J, and Peterson E. Skin T cell lymphoma: A previously baffling diagnosis unraveled. "Dermatol Clin" published the article in 2019 with the DOI: 37: 455–69.
